BioTech Industry

Catch Duchenne Patient Power, Phil Sharp & More Next Week at The Broad

7 monthes ago   |   By Xconomy

How did Phil Sharp, a kid from a small farm in Kentucky, become a Nobel prize winner and one of the godfathers of the biotech industry? How did Christine McSherry turn her youngest son's devastating diagnosis into a crusade that aided in the approval of a drug for his disease? Sharp and McSherry will share the stories behind these questions next week at Xconomy's latest Boston biotech event. On Oct. 17 at the Broad Institute in Cambridge, MA, Xconomy will host “ Boston's Life Science Disruptors ,” a series of interactive discussions with entrepreneurs who have had a big...
Read more ...

 


Search by Tags

   BioTech Industry      Life Science      BioTech      AIDS      Industrial      Biotech      Science      Drug      Drugs      Boston      Boston blog main      Boston top stories      National blog main      New York blog main      New York top stories      Boston's Life Science Disruptors      Burt Adelman      Christine McSherry      Disruptors      Events      Life Science Disruptors      Life Sciences      People      Phil Sharp      Sekar Kathiresan      Startups      The Broad Institute      Verve Therapeutics  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Merck Outlines COVID-19 Ambitions With Buyout Deal, Collaborations

Merck Outlines COVID-19 Ambitions With Buyout Deal, Collaborations

Merck exited the holiday weekend with some fireworks of its own, announcing three major programs on Tuesday all related to investments in finding ways to treat and prevent... Read more ...

Insitro Adds $143M to Fuel Machine Learning-Driven Drug Development

Insitro Adds $143M to Fuel Machine Learning-Driven Drug Development

A stem cell biologist, a gene editing expert, and a data engineer walk into a room...and that's just a few of the people Daphne Koller has recruited in the past two years to... Read more ...

Site of LUX-ZEPLIN Dark Matter Search Project Carefully Ramps Up Science Work

Site of LUX-ZEPLIN Dark Matter Search Project Carefully Ramps Up Science Work

A photomultiplier tube array that is part of the LUX-ZEPLIN experiment at the Sanford Underground Research Facility in Lead, South Dakota. The photomultiplier tubes are... Read more ...

Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments

Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments

Privately held biotech ViaCyte has banked $27 million, the majority an installment of cash from a tranched $80 million Series D financing round it closed in late 2018. The... Read more ...

COVID-19 Sparks New Opportunities for Digital Health Companies

COVID-19 Sparks New Opportunities for Digital Health Companies

Clinicians and regulators are rethinking how healthcare is provided amid precautions prompted by COVID-19. In-person physician visits don't fit within the physical distancing... Read more ...

Bristol Myers Squibb Company: Associate Director of San Diego Global Capital...

Bristol Myers Squibb Company: Bristol-Myers Squibb is a global Biopharma company committed to a single mission: to discover, develop, and deliver innovative medicines focused... Read more ...

Sorrento Receives FDA IND Clearance to Initiate a Phase I Clinical Trial of...

SAN DIEGO, May 26, 2020 - Sorrento Therapeutics, Inc. today announced it has received clearance from the U.S. Food and Drug Administration for its investigational new drug... Read more ...

Public Disclosure of COVID-19 Cases Is More Effective than Lockdowns

Read more ...

Gerald Joyce elected to Royal Swedish Academy of Sciences

LA JOLLA-Salk Professor Gerald Joyce, a pioneer in the field of in vitro evolution, has been elected to the prestigious Royal Swedish Academy of Sciences as a foreign member... Read more ...

Sugars that coat proteins are a possible drug target for pancreatitis

LA JOLLA-Pancreatitis is an inflammation of the pancreas that accounts for 275,000 hospitalizations in the United States annually. Patients who suffer from hereditary... Read more ...